rs7081062
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001367943.1(TCF7L2):c.450+16362G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.637 in 152,098 control chromosomes in the GnomAD database, including 31,069 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.64 ( 31069 hom., cov: 33)
Consequence
TCF7L2
NM_001367943.1 intron
NM_001367943.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.588
Publications
9 publications found
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
TCF7L2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- intellectual disabilityInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- congenital glaucomaInheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.694 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCF7L2 | NM_001367943.1 | c.450+16362G>A | intron_variant | Intron 4 of 14 | ENST00000355995.9 | NP_001354872.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.637 AC: 96748AN: 151980Hom.: 31045 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
96748
AN:
151980
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.637 AC: 96816AN: 152098Hom.: 31069 Cov.: 33 AF XY: 0.632 AC XY: 46958AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
96816
AN:
152098
Hom.:
Cov.:
33
AF XY:
AC XY:
46958
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
28665
AN:
41504
American (AMR)
AF:
AC:
8368
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
2324
AN:
3466
East Asian (EAS)
AF:
AC:
3694
AN:
5178
South Asian (SAS)
AF:
AC:
3104
AN:
4828
European-Finnish (FIN)
AF:
AC:
5900
AN:
10556
Middle Eastern (MID)
AF:
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42548
AN:
67966
Other (OTH)
AF:
AC:
1411
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1853
3706
5560
7413
9266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2172
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.